Psychiatric Times Editors

B. ECT is a viable treatment and I would recommend it in some cases

C. ECT is use an approved treatment but I would not recommend it

For more on this topic, see the Point/Counterpoint:

Electroconvulsive Therapy: Obsolete and Dangerous or Still Just Misunderstood?

ECT: Dangerous on Either Side of the Pond


John Read, PhD, Sarah Hancock, MS, CRC, Sue Cunliffe, MBchB, RCPCH

Articles

Is ECT a viable or a dangerous treatment for psychiatric disorders? Is there a middle road? Share your thoughts in our poll.

PsychPoll: ECT, Yay or Nay?

For the full report of survey results, see 

You Spoke, We Listened. Psychiatry's Cannabis Survey

Clinical Management of Cannabis Complications


Thomas R. Kosten, MD, and Christopher D. Verrico, PhD

The Age of Cannabis Has Arrived: Issues for Older Adults

Cannabis 2021: What Clinicians Need to Know

Cannabis and Psychosis: A Synthesis of Quantitative Reviews

How to Discuss Cannabis With Your Patients

Infographic: A Snapshot of Psychiatrists' Attitudes Toward Cannabis

Slideshows

Research on psychiatrists' attitudes on the potential of cannabis in psychiatry.

Infographic: A Snapshot of  Psychiatrists' Attitudes Toward Cannabis

Enlightening survey results reveal what psychiatrists think about medical marijuana/cannabis use, how or whether to discuss with their patients, and what biases might get in the way of such conversations.


In the event adverse effects emerge, such as GI complaints, dizziness, weight loss or gain, or decreased libido. educate and discuss these issues with patients, Focus on tolerance in follow-up visits. It is important to distinguish adverse effects from symptoms and to lower the dose or change the dosing schedule if necessary. Or, consider adjunct treatment. 

Managing the Adverse Effects of Antidepressants

Poll

How often do your patients share with you the positive and negative effects of medications?

All About Adverse Effects: Psychotropics Poll

 on our various social platforms and via email! 

Our robust social media platforms enable health professionals to share the vision of optimal mental health and to connect, collaborate, and discuss issues related to psychiatry. 

Engage with your colleagues on our platforms, including a professional 

. All the information you need is listed below.

Share comments with your colleagues by emailing 

. Comments may be shared online pending review and editing for style. 

Join the conversation on Psychiatric Times

Are You Connected?

Discussions With Patients: Medical Marijuana


Less Risky Than Believed: Alcohol and Cannabis Combinations


What are your thought about navigating these uncharted waters?

Poll: On the Realities of Legalizing Marijuana

The most common comorbid disorders in geriatric patients with hoarding disorder (HD) are major depressive disorder, OCD, generalized anxiety disorder, and dysthymia.

During the intake session with an older adult in whom hoarding disorder (HD) is suspected, it is important to assess for other psychiatric disorders that may affect the presentation and treatment of symptoms. Presence of a comorbid disorder significantly predicts symptom severity in geriatric patients, with the exception of alcohol use.

Hoarding in Late Life: Implications for Clinicians

,” by Mary E. Dozier and Catherine Ayers, PhD, on which this quiz was based. (This quiz was originally posted on February 12, 2015, and has since been updated. -Ed)

When hoarding disorder is suspected, it is important to assess for other psychiatric disorders that may affect the presentation and treatment of symptoms. Find out more in this quiz.

Mini Quiz: Hoarding Disorder in the Elderly

Less Risky Than Believed: Alcohol and Cannabis Combinations

What are your thoughts about prescribing medical marijuana/cannabis to treat psychiatric disorders?

Poll: Prescribing Cannabis

Medical Marijuana and Mental Health: Cannabis Use in Psychiatric Practice

What are your feelings about the utility of cannabis in psychiatric practice?

Professional Opinion: Cannabis

As our knowledge about herbal cannabis, the endocannabinoid system, and cannabinoid pharmacology expands, should psychiatrists discuss these issues with their patients?